# US 2010/0143977 A1 · Genetically modified strains producing anthracycline metabolites useful as cancer drugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0143977 A1
- Document ID: US20100143977A1
- Status: Published application
- Kind: A1
- Application number: 12/598,806
- Filed: 2008-04-29
- Published: 2010-06-10
- Earliest claimed: 2007-05-08
- Assignees: W.C. Heraeus GmbH
- Inventors: Michael Lambert; Kristiina Ylihonko
- Web page: https://patentgrep.com/patent/US20100143977A1

## CPC

- C12P 19/56: having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention refers to a microbial strain, which produces anthracycline metabolites at a titre of at least 0.5 g/l fermentation broth.

## Claims

### Claim 1

A microbial strain that produces anthracycline metabolites at a titre of at least 0.5 g/l fermentation broth.

### Claim 2 (depends on 1)

The strain according to claim 1, which produces at least 0.1 g/l fermentation broth of each of the compounds epidaunorubicin, 13-dihydro-epidaunorubicin, 4′-epi-feudomycin and ε-rhodomycinone.

### Claim 3 (depends on 1)

The strain according to claim 1, which produces at least one of the compounds epidaunorubicin, 13-dihydro-epidaunorubicin, 4′-epi-feudomycin and ε-rhodomycinone in at least 10% of the total anthracycline metabolite fraction.

### Claim 4 (depends on 1)

The strain according to claim 1, wherein the biosynthesis of endogeneous daunomycin metabolites is blocked.

### Claim 5 (depends on 4)

The strain according to claim 4, wherein baumycin production is blocked by random mutagenization.

### Claim 6 (depends on 1)

The strain according to claim 1, which carries genes for 4′ketoreductase and for O-methylation.

### Claim 7 (depends on 6)

The strain according to claim 6, wherein said genes are ekr8 and rdmB.

### Claim 8 (depends on 1)

The strain according to claim 1, wherein said strain is selected from the genera Streptomyces.

### Claim 9 (depends on 8)

The strain according to claim 8, wherein said strain is selected from the species Streptomyces peucetius.

### Claim 10 (depends on 9)

The strain according to claim 9, wherein said strain is selected from the species Streptomyces peucetius var. caesius.

### Claim 11 (depends on 1)

A process for producing anthracycline metabolites comprising fermenting a microbial producer strain according to claim 1.

### Claim 12 (depends on 11)

The process according to claim 11, wherein said anthracycline metabolites are selected from the group consisting of epidaunomycins and ε-rhodomycinone.

### Claim 13 (depends on 12)

The process according to claim 12, wherein said anthracycline metabolites are selected from the group consisting of epidaunorubicin, 13-dihydroepidaunorubicin, 4′-epi-feudomcyin and ε-rhodomycinone.

### Claim 14 (depends on 1)

The process according to claim 1, which further comprises absorbing crude epidaunomycins and ε-rhodomycinone from the fermentation broth by adding a resin at any time.

### Claim 15 (depends on 14)

The process according to claim 14, wherein said resin is selected from the group consisting of ionic and non-ionic adsorbents.

### Claim 16 (depends on 15)

The process according to claim 15, wherein said resin is selected from the group consisting of polystyrenes.

### Claim 17 (depends on 16)

The process according to claim 16, wherein said resin is selected from the group consisting of XAD-7 and Diaion HP-20.

### Claim 18 (depends on 14)

The process according to claim 14, which further comprises addine said resin in an amount of 1-100 g/l.

### Claim 19 (depends on 18)

The process according to claim 18, which further comprises adding said resin in an amount of 15-40 g/l.
